CONSOLIDATED BALANCE SHEETS - USD ($)		Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents		$ 15,557,000	$ 58,192,000
Restricted cash		0	18,609,000
Accounts receivable, net		21,851,000	22,761,000
Inventories		161,000	2,928,000
Due from related parties		14,000	40,000
Prepaid expenses and other current assets		2,748,000	4,217,000
Assets held for sale, current		2,991,000	0
Total current assets		43,322,000	106,747,000
Property, plant and equipment, net		14,069,000	56,072,000
Operating lease right-of-use assets		7,213,000	0
Intangible assets, net		31,362,000	115,313,000
Goodwill		159,675,000	284,268,000
Equity investment		21,200,000	0
Other assets		438,000	6,907,000
Assets held for sale, noncurrent		62,525,000	0
Total assets		339,804,000	569,307,000
Current liabilities:
Accounts payable		17,983,000	13,604,000
Accrued expenses		38,763,000	36,084,000
Deferred revenue		2,738,000	2,649,000
Due to related party		229,000	47,000
Income tax payable		388,000	739,000
Related-party debt, current		0	657,000
Debt, current		0	22,093,000
Forward share purchase liability		0	18,051,000
Lease liabilities, current		5,475,000	2,404,000
Other liabilities, current		74,000	376,000
Liabilities held for sale, current		3,319,000	0
Total current liabilities		68,969,000	96,704,000
Related-party debt, noncurrent		281,000	331,000
Debt, noncurrent		145,962,000	98,417,000
Deferred tax liabilities		1,200,000	28,281,000
Warrant liabilities, noncurrent		9,000	252,000
Derivative liability, noncurrent		56,000	7,977,000
Lease liabilities, noncurrent		8,741,000	2,644,000
Other liabilities, noncurrent		662,000	858,000
Liabilities held for sale, noncurrent		7,787,000	0
Total liabilities		233,667,000	235,464,000
Commitments and Contingencies (Note 19)
Stockholders' Equity Attributable to Parent [Abstract]
Common stock, $0.0001 par value, 30,000 shares authorized, 15,054 and 14,428 issued and outstanding as of December 31, 2022 and 2021, respectively	[1]	2,000	1,000
Additional paid in capital		688,355,000	665,474,000
Treasury stock, at cost		(17,000,000)	0
Accumulated deficit		(566,209,000)	(343,209,000)
Accumulated other comprehensive loss		0	(3,802,000)
Total UpHealth, Inc., stockholders’ equity		105,148,000	318,464,000
Noncontrolling interests		989,000	15,379,000
Total stockholders’ equity	[2]	106,137,000	333,843,000
Total liabilities and stockholders’ equity		$ 339,804,000	$ 569,307,000

[1] Amounts as of December 31, 2021 differ from those published in our prior consolidated financial statements as they were retrospectively adjusted as a result of the Reverse Stock Split (as described below in Note 1, Organization and Business). Specifically, the number of common shares outstanding during periods before the Reverse Stock Split are divided by the exchange ratio of 10:1, such that each ten shares of common stock were combined and reconstituted into one share of common stock effective December 8, 2022.

[2] (2) Amounts as of September 30, 2022 and before that date differ from those published in our prior condensed consolidated financial statements as they were retrospectively adjusted as a result of the Reverse Stock Split (as described below in Note 1, Organization and Business). Specifically, the number of common shares outstanding during periods before the Reverse Stock Split are divided by the exchange ratio of 10:1, such that each ten shares of common stock were combined and reconstituted into one share of common stock effective December 8, 2022.